Minireviews
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Transplant. Mar 18, 2025; 15(1): 99220
Published online Mar 18, 2025. doi: 10.5500/wjt.v15.i1.99220
Expanding role of antibodies in kidney transplantation
Khawar Abbas, Muhammed Mubarak
Khawar Abbas, Department of Transplant Immunology, Sindh Institute of Urology & Transplantation, Karachi 74200, Sindh, Pakistan
Muhammed Mubarak, Javed I. Kazi Department of Histopathology, Sindh Institute of Urology & Transplantation, Karachi 74200, Sindh, Pakistan
Author contributions: Abbas K and Mubarak M contributed equally to the conception and study design. All authors performed relevant research, participated in primary and final drafting, and read and approved the final manuscript.
Conflict-of-interest statement: No conflict of interest to declare.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Khawar Abbas, FCPS, MBBS, Professor, Department of Transplant Immunology, Sindh Institute of Urology & Transplantation, Chand Bibi Road, Karachi 74200, Sindh, Pakistan. drkhawar_imuno@yahoo.com
Received: July 17, 2024
Revised: October 21, 2024
Accepted: November 7, 2024
Published online: March 18, 2025
Processing time: 133 Days and 3.8 Hours
Core Tip

Core Tip: Antibodies are of crucial importance in kidney transplantation (KT), posing challenges such as antibody-mediated rejection (AMR) but also offering opportunities for better transplant outcomes through advanced detection, prevention, and treatment strategies. This review explores the role of antibodies in rejection, progress in desensitization, AMR treatments, and their potential to enhance graft survival, reflecting evolving strategies to manage and leverage antibodies in KT.